• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞信号转导靶点增强调节或效应功能。

T cell signaling targets for enhancing regulatory or effector function.

机构信息

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

出版信息

Sci Signal. 2012 Jul 31;5(235):pe32. doi: 10.1126/scisignal.2003364.

DOI:10.1126/scisignal.2003364
PMID:22855503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4659372/
Abstract

To respond to infection, resting or naïve T cells must undergo activation, clonal expansion, and differentiation into specialized functional subsets of effector T cells. However, to prevent excessive or self-destructive immune responses, regulatory T cells (T(regs)) are instrumental in suppressing the activation and function of effector cells, including effector T cells. The transcription factor Forkhead box P3 (Foxp3) regulates the expression of genes involved in the development and function of T(regs). Foxp3 interacts with other transcription factors and with epigenetic elements such as histone deacetylases (HDACs) and histone acetyltransferases. T(reg) suppressive function can be increased by exposure to HDAC inhibitors. The individual contributions of different HDAC family members to T(reg) function and their respective mechanisms of action, however, remain unclear. A study showed that HDAC6, HDAC9, and Sirtuin-1 had distinct effects on Foxp3 expression and function, suggesting that selectively targeting HDACs individually or in combination may enhance T(reg) stability and suppressive function. Another study showed that the receptor programmed death 1 (PD-1), a well-known inhibitor of T cell activation, halted cell cycle progression in effector T cells by inhibiting the transcription of the gene encoding the substrate-recognition component (Skp2) of the ubiquitin ligase SCF(Skp2). Together, these findings reveal new signaling targets for enhancing T(reg) or effector T cell function that may be helpful in designing future therapies, either to increase T(reg) suppressive function in transplantation and autoimmune diseases or to block PD-1 function, thus increasing the magnitude of antiviral or antitumor immune responses of effector T cells.

摘要

为了应对感染,静息或幼稚 T 细胞必须经历激活、克隆扩增,并分化为效应 T 细胞的专门功能亚群。然而,为了防止过度或自毁性的免疫反应,调节性 T 细胞(Tregs)在抑制效应细胞(包括效应 T 细胞)的激活和功能方面发挥着重要作用。转录因子叉头框 P3(Foxp3)调节参与 Tregs 发育和功能的基因的表达。Foxp3 与其他转录因子相互作用,并与表观遗传元件(如组蛋白去乙酰化酶(HDACs)和组蛋白乙酰转移酶)相互作用。Treg 的抑制功能可通过暴露于 HDAC 抑制剂来增强。然而,不同的 HDAC 家族成员对 Treg 功能的个体贡献及其各自的作用机制仍不清楚。一项研究表明,HDAC6、HDAC9 和 Sirtuin-1 对 Foxp3 的表达和功能有不同的影响,这表明选择性地针对单个或组合的 HDAC 可能增强 Treg 的稳定性和抑制功能。另一项研究表明,受体程序性死亡 1(PD-1),一种众所周知的 T 细胞激活抑制剂,通过抑制泛素连接酶 SCF(Skp2)的底物识别组件(Skp2)基因的转录,阻止效应 T 细胞的细胞周期进程。这些发现共同揭示了增强 Treg 或效应 T 细胞功能的新信号靶点,这可能有助于设计未来的治疗方法,无论是增加移植和自身免疫疾病中 Treg 的抑制功能,还是阻断 PD-1 功能,从而增强效应 T 细胞的抗病毒或抗肿瘤免疫反应的幅度。

相似文献

1
T cell signaling targets for enhancing regulatory or effector function.T 细胞信号转导靶点增强调节或效应功能。
Sci Signal. 2012 Jul 31;5(235):pe32. doi: 10.1126/scisignal.2003364.
2
Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.组蛋白去乙酰化酶 6 和 9 以及 Sirtuin-1 通过共享和同工型特异性机制控制 Foxp3+调节性 T 细胞的功能。
Sci Signal. 2012 Jun 19;5(229):ra45. doi: 10.1126/scisignal.2002873.
3
Deacetylase inhibition promotes the generation and function of regulatory T cells.去乙酰化酶抑制作用可促进调节性T细胞的生成及功能。
Nat Med. 2007 Nov;13(11):1299-307. doi: 10.1038/nm1652. Epub 2007 Oct 7.
4
Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.组蛋白/蛋白质去乙酰化酶控制 Foxp3 的表达和 T 调节细胞的热休克反应。
Curr Opin Immunol. 2011 Oct;23(5):670-8. doi: 10.1016/j.coi.2011.07.002. Epub 2011 Jul 26.
5
T(reg) stability: to be or not to be.调节性T细胞的稳定性:存在与否
Curr Opin Immunol. 2016 Apr;39:39-43. doi: 10.1016/j.coi.2015.12.009. Epub 2016 Jan 15.
6
Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.白细胞介素-7 将抑制性 CD127(+) 叉头框 P3 (FoxP3)(+) T 细胞成熟为 CD127(-) CD25(高) FoxP3(+) 调节性 T 细胞。
Clin Exp Immunol. 2011 Jul;165(1):60-76. doi: 10.1111/j.1365-2249.2011.04334.x. Epub 2011 Mar 17.
7
FOXP3+ regulatory T cells in the human immune system.FOXP3+ 调节性 T 细胞在人类免疫系统中的作用。
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.
8
Foxp3 occupancy and regulation of key target genes during T-cell stimulation.T细胞刺激过程中Foxp3对关键靶基因的占据及调控
Nature. 2007 Feb 22;445(7130):931-5. doi: 10.1038/nature05478. Epub 2007 Jan 21.
9
Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?T(reg)细胞的可塑性:FOXP3 存在的情况下 T(reg)细胞的重编程是否可能?
Int Immunopharmacol. 2011 May;11(5):555-60. doi: 10.1016/j.intimp.2010.11.024. Epub 2010 Nov 27.
10
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.Foxp3+调节性T细胞:分化、特性、亚表型
Nat Immunol. 2009 Jul;10(7):689-95. doi: 10.1038/ni.1760.

引用本文的文献

1
Comprehensive in vitro characterization of PD-L1 small molecule inhibitors.全面的 PD-L1 小分子抑制剂的体外表征。
Sci Rep. 2019 Aug 27;9(1):12392. doi: 10.1038/s41598-019-48826-6.
2
Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes.使用 CRISPR/Cas9 编辑技术在原代人 T 淋巴细胞中激活 NRF2 治疗。
J Immunol. 2018 Mar 1;200(5):1929-1936. doi: 10.4049/jimmunol.1700812. Epub 2018 Jan 19.
3
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy.表观遗传药物与免疫疗法联合应用:提高抗癌疗效的新途径。
Clin Epigenetics. 2017 May 30;9:59. doi: 10.1186/s13148-017-0358-y. eCollection 2017.
4
Prenatal high-dose vitamin D3 supplementation has balanced effects on cord blood Th1 and Th2 responses.产前补充高剂量维生素D3对脐带血Th1和Th2反应具有平衡作用。
Nutr J. 2016 Aug 9;15(1):75. doi: 10.1186/s12937-016-0194-5.
5
Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.免疫疗法中的表观遗传修饰剂:聚焦于检查点抑制剂。
Immunotherapy. 2016 Jun;8(6):705-19. doi: 10.2217/imt-2016-0014.
6
Histone deacetylation of memory T lymphocytes by You-Gui-Wan alleviates allergen-induced eosinophilic airway inflammation in asthma.右归丸对记忆性T淋巴细胞进行组蛋白去乙酰化可减轻哮喘中变应原诱导的嗜酸性气道炎症。
Chin Med. 2015 May 13;10:9. doi: 10.1186/s13020-015-0038-9. eCollection 2015.
7
Anti-inflammatory therapy in chronic disease: challenges and opportunities.慢性病的抗炎治疗:挑战与机遇。
Science. 2013 Jan 11;339(6116):166-72. doi: 10.1126/science.1230720.

本文引用的文献

1
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.PD-1 对 Akt 和 Ras 通路的选择性作用调节细胞周期的分子成分并抑制 T 细胞增殖。
Sci Signal. 2012 Jun 26;5(230):ra46. doi: 10.1126/scisignal.2002796.
2
Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.组蛋白去乙酰化酶 6 和 9 以及 Sirtuin-1 通过共享和同工型特异性机制控制 Foxp3+调节性 T 细胞的功能。
Sci Signal. 2012 Jun 19;5(229):ra45. doi: 10.1126/scisignal.2002873.
3
Histone/protein deacetylases and T-cell immune responses.组蛋白/蛋白质去乙酰化酶与 T 细胞免疫应答。
Blood. 2012 Mar 15;119(11):2443-51. doi: 10.1182/blood-2011-10-292003. Epub 2012 Jan 12.
4
Regulatory T cell therapy for the induction of clinical organ transplantation tolerance.调节性 T 细胞治疗诱导临床器官移植耐受。
Semin Immunol. 2011 Dec;23(6):453-61. doi: 10.1016/j.smim.2011.08.012. Epub 2011 Sep 14.
5
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.缺氧诱导因子 1 对 T(H)17/T(reg) 平衡的调控。
Cell. 2011 Sep 2;146(5):772-84. doi: 10.1016/j.cell.2011.07.033. Epub 2011 Aug 25.
6
HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.HIF1alpha 依赖性糖酵解途径为 TH17 和 Treg 细胞的分化协调代谢检查点。
J Exp Med. 2011 Jul 4;208(7):1367-76. doi: 10.1084/jem.20110278. Epub 2011 Jun 27.
7
Regulatory T cells: customizing for the clinic.调节性 T 细胞:为临床定制。
Sci Transl Med. 2011 May 18;3(83):83ps19. doi: 10.1126/scitranslmed.3001819.
8
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.调节性 T 细胞可预防 HLA 单倍体相合移植中的移植物抗宿主病并促进免疫重建。
Blood. 2011 Apr 7;117(14):3921-8. doi: 10.1182/blood-2010-10-311894. Epub 2011 Feb 3.
9
Phenotypical and functional specialization of FOXP3+ regulatory T cells.FOXP3+ 调节性 T 细胞的表型和功能特化。
Nat Rev Immunol. 2011 Feb;11(2):119-30. doi: 10.1038/nri2916.
10
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.成人脐带血移植中体外扩增的调节性 T 细胞输注:安全性概况和检测动力学。
Blood. 2011 Jan 20;117(3):1061-70. doi: 10.1182/blood-2010-07-293795. Epub 2010 Oct 15.